文献速递肝病

体力衰弱的肝移植患者

Liver transplantation in the patient with physical frailty.
PubMed 文献 · J Hepatol · 2023-01-01

本文综述体力衰弱与肌少症在接受肝移植患者中的定义、评估与影响。体力衰弱指数侧重收缩功能障碍,肌肉面积影像分析是定义肌少症最可接受且可重复的方法;二者在等待名单患者中常见,并与移植前后死亡、住院、感染及医疗费用等不良结局相关。营养干预与体力活动仍是移植前后管理的主要手段,尽管大规模试验数据有限。

要点

  • 体力衰弱指数评估收缩功能障碍,肌肉面积影像分析用于定义肌少症。
  • 体力衰弱/肌少症在肝移植候选者中常见,并与移植前后不良结局相关。
  • 营养干预与体力活动是移植前后管理的主要手段,但大规模试验数据有限。

核心结论

  • 体力衰弱与肌少症在肝移植前后常见并影响临床结局,营养干预与体力活动仍是管理主要手段,尽管大规模试验数据有限。
  • 除体力衰弱外,还需以多学科方法评估认知、情绪、心理社会等其他衰弱成分。
  • 对肌少症与收缩功能障碍机制的近期认识有助于发现新的治疗靶点。

研究设计与样本

  • 综述,围绕体力衰弱与肌少症在肝移植患者中的定义、评估、结局与管理进行总结。
  • 检索范围原文未报告。

主要发现

  • 体力衰弱指数(包括肝衰弱指数)侧重收缩功能障碍,即体力衰弱。
  • 肌肉面积的横断面影像分析是定义肌少症最可接受且可重复的测量方法。
  • 体力衰弱/肌少症在肝移植候选者中患病率高,并与移植前后死亡、住院、感染及医疗费用等不良结局相关。
  • 关于患病率及其性别与年龄依赖的结局影响,在肝移植等待名单患者中的数据并不一致。
  • 体力衰弱与肌少症性肥胖在肥胖肝硬化患者中常见,并对肝移植后结局产生不良影响。

临床怎么用

  • 营养干预与体力活动仍是移植前后管理的主要手段,尽管大规模试验数据有限。
  • 除体力衰弱外,还需以多学科方法评估认知、情绪、心理社会等其他衰弱成分。
  • 原文未据此给出其他推荐。

局限性

  • 营养干预与体力活动作为管理主要手段的依据为有限的大规模试验数据。
  • 关于患病率及其性别与年龄依赖的结局影响,在肝移植等待名单患者中的数据并不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Frailty is a decline in functional reserve across multiple physiological systems. A key component of frailty is sarcopenia, which denotes a loss of skeletal muscle mass and impaired contractile function that ultimately result in physical frailty. Physical frailty/sarcopenia are frequent and contribute to adverse clinical outcomes before and after liver transplantation. Frailty indices, including the liver frailty index, focus on contractile dysfunction (physical frailty), while cross-sectional image analysis of muscle area is the most accepted and reproducible measure to define sarcopenia. Thus, physical frailty and sarcopenia are interrelated. The prevalence of physical frailty/sarcopenia is high in liver transplant candidates and these conditions have been shown to adversely impact clinical outcomes including mortality, hospitalisations, infections, and cost of care both before and after transplantation. Data on the prevalence of frailty/sarcopenia and their sex- and age-dependent impact on outcomes are not consistent in patients on the liver transplant waitlist. Physical frailty and sarcopenic obesity are frequent in the obese patient with cirrhosis, and adversely affect outcomes after liver transplantation. Nutritional interventions and physical activity remain the mainstay of management before and after transplantation, despite limited data from large scale trials. In addition to physical frailty, there is recognition that a global evaluation including a multidisciplinary approach to other components of frailty (e.g., cognition, emotional, psychosocial) also need to be addressed in patients on the transplant waitlist. Recent advances in our understanding of the underlying mechanisms of sarcopenia and contractile dysfunction have helped identify novel therapeutic targets.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Tandon P, Zanetto A, Piano S, et al. Liver transplantation in the patient with physical frailty. J Hepatol. 2023. PMID: 37208097. doi:10.1016/j.jhep.2023.03.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。